Evidence map›Paper›PMID 37260024›Full record

ArticleJournal of the American Heart Association2023

Exercise Capacity and Ventilatory Efficiency in Patients With Pulmonary Arterial Hypertension.

Kazuki Tobita, Ayumi Goda, Koji Teruya, Yuichiro Nishida, Kaori Takeuchi, Hanako Kikuchi, Takumi Inami, Takashi Kohno, Syoichi Tashiro, Shin Yamada and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Does COVID-19 impair V̇oJournal of applied physiology (Bethesda, Md. : 1985) · 2023
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Kazuki TobitaDepartment of Rehabilitation Kyorin University Hospital Tokyo Japan.
Ayumi GodaDepartment of Cardiovascular Medicine Kyorin University School, Faculty of Medicine Tokyo Japan.ORCID 0000-0002-4388-7639
Koji TeruyaDepartment of Public Health Kyorin University, Facullty of Health Sciences Tokyo Japan.ORCID 0000-0002-2787-4184
Yuichiro NishidaDepartment of Rehabilitation Kyorin University Hospital Tokyo Japan.
Kaori TakeuchiDepartment of Cardiovascular Medicine Kyorin University School, Faculty of Medicine Tokyo Japan.ORCID 0000-0001-6307-8110
Hanako KikuchiDepartment of Cardiovascular Medicine Kyorin University School, Faculty of Medicine Tokyo Japan.
Takumi InamiDepartment of Cardiovascular Medicine Kyorin University School, Faculty of Medicine Tokyo Japan.
Takashi KohnoDepartment of Cardiovascular Medicine Kyorin University School, Faculty of Medicine Tokyo Japan.ORCID 0000-0003-2604-1284
Syoichi TashiroDepartment of Rehabilitation Kyorin University Hospital Tokyo Japan.
Shin YamadaDepartment of Rehabilitation Kyorin University Hospital Tokyo Japan.ORCID 0000-0003-3061-0267
Toru SatohDepartment of Cardiovascular Medicine Kyorin University School, Faculty of Medicine Tokyo Japan.ORCID 0000-0002-6498-1966
Kyoko SoejimaDepartment of Cardiovascular Medicine Kyorin University School, Faculty of Medicine Tokyo Japan.ORCID 0000-0002-0685-4563
Kyorin University · JPKyorin University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background The symptom for identification of pulmonary arterial hypertension (PAH) is dyspnea on exertion, with a concomitant decrease in exercise capacity. Even patients with hemodynamically improved PAH may have impaired exercise tolerance; however, the effect of central and peripheral factors on exercise tolerance remains unclear. We explored the factors contributing to exercise capacity and ventilatory efficiency in patients with hemodynamically normalized PAH after medical treatment. Methods and Results In total, 82 patients with PAH (age: median 46 [interquartile range, 39-51] years; male:female, 23:59) and mean pulmonary arterial pressure ≤30 mm Hg at rest were enrolled. The exercise capacity, indicated by the 6-minute walk distance and peak oxygen consumption, and the ventilatory efficiency, indicated by the minute ventilation versus carbon dioxide output slope, were assessed using cardiopulmonary exercise testing with a right heart catheter. The mean pulmonary arterial pressure was 21 (17-25) mm Hg, and the 6-minute walk distance was 530 (458-565) m, whereas the peak oxygen consumption was 18.8 (14.8-21.6) mLꞏmin

Indexed as

Hypertension, PulmonaryPulmonary Arterial HypertensionAdultCarbon DioxideExercise TestExercise ToleranceFamilial Primary Pulmonary HypertensionFemaleHumansMaleMiddle AgedOxygenOxygen ConsumptionCarbon DioxideOxygen6‐minute walk distanceexercise capacityhemodynamicsmuscle strengthpulmonary arterial hypertensionventilatory efficiency

Identifiers

PMID37260024
PMCPMC10382004
OpenAlexW4378952491

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.